Same Drug Class

Methotrexate vs Osimertinib

Methotrexate vs Osimertinib: Overview

This comparison examines the pharmacological differences between Methotrexate and Osimertinib.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5; Osimertinib — C28H33N7O2.

Molecular Weight: Methotrexate — 454.4400 g/mol; Osimertinib — 499.6050 g/mol.

Type: Methotrexate — Small molecule; Osimertinib — Small molecule.